Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 18, 2019
Reporting Period: Fiscal fourth quarter and full year ended December 31, 2018.
This filing serves to announce the company's financial results for the specified period via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. The filing states that results for revenue, profit, cash flow, margins, debt, and liquidity are detailed in the press release (Exhibit 99.1) but does not list these values directly in the text provided.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms the announcement of results for the fourth quarter and fiscal year 2018.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These elements are presumed to be contained within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 18, 2019) for actual revenue, net income, and cash flow figures.
- Verify year-over-year growth rates and margin trends for Q4 and full-year 2018.
- Check for any updated financial guidance or strategic outlook provided in the press release.
- Confirm the status of debt obligations and liquidity positions as of December 31, 2018.